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Wei et al. report that Cdk5rap1 is
responsible for 2-methylthio (ms2)
modifications of mammalian mt-tRNAs.
The modification is critical for efficient
mitochondrial translation in mice and
dysregulated in MELAS patients.
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Transfer RNAs (tRNAs) contain a wide variety of post-
transcriptional modifications that are important for
accurate decoding. Mammalian mitochondrial tRNAs
(mt-tRNAs) are modified by nuclear-encoded tRNA-
modifying enzymes; however, the physiological roles
of thesemodifications remain largely unknown. In this
study, we report that Cdk5 regulatory subunit-associ-
ated protein 1 (Cdk5rap1) is responsible for 2-methyl-
thio (ms2) modifications of mammalian mt-tRNAs for
Ser(UCN), Phe, Tyr, and Trp codons. Deficiency in
ms2 modification markedly impaired mitochondrial
protein synthesis, which resulted in respiratory de-
fects in Cdk5rap1 knockout (KO) mice. The KO mice
were highly susceptive to stress-induced mitochon-
drial remodeling and exhibited acceleratedmyopathy
and cardiac dysfunction under stressed conditions.
Furthermore, we demonstrate that the ms2 modifica-
tions of mt-tRNAs were sensitive to oxidative stress
and were reduced in patients with mitochondrial
disease. These findings highlight the fundamental
role of ms2 modifications of mt-tRNAs in mitochon-
drial protein synthesis and their pathological conse-
quences in mitochondrial disease.
INTRODUCTION
Transfer RNA (tRNA) is a key molecule in the translational appa-
ratus to decode genetic information into proteins. A unique
feature of tRNAs is the presence of a variety of chemical modifi-
cations of their nucleotides (Machnicka et al., 2013). Thesemod-
ifications are critical for efficient and accurate decoding (Agris,
2004; Suzuki, 2005). To date, more than 100 modified nucleo-428 Cell Metabolism 21, 428–442, March 3, 2015 ª2015 Elsevier Inc.tides have been identified in tRNAs from the three domains of
life, indicative of the universal importance of tRNA modifications
(Machnicka et al., 2013).
Given the critical roles of tRNA modifications in cells, it is not
surprising that tRNAmodification deficiencies have been associ-
ated with human diseases (Torres et al., 2014). Genetic varia-
tions in the gene encoding Cdk5 regulatory subunit associated
protein 1-like-1 (CDKAL1), which inserts a 2-methylthio (ms2)
group into theN6-threonylcarbamoyl adenosine (t6A) of cytosolic
tRNALys(UUU), have been associated with the development of
type 2 diabetes (Steinthorsdottir et al., 2007; Arragain et al.,
2010). A deficiency in the ms2 modification of tRNALys(UUU) re-
sulted in aberrant proinsulin synthesis, which ultimately led to
impaired glucose metabolism and insulin secretion in Cdkal1
knockout (KO) mice and in human subjects carrying T2D-associ-
ated alleles of CDKAL1 (Wei et al., 2011; Xie et al., 2013).
In mitochondrial tRNAs (mt-tRNAs), 15 species of modified
nucleotides at 118 positions have been identified in bovine (Su-
zuki and Suzuki, 2014). Some of these modifications have been
associated with the development of mitochondrial diseases,
such asMitochondrial myopathy, encephalopathy, lactic cidosis,
stroke-like episodes (MELAS), and myoclonus epilepsy with rag-
ged-red fibers (MERRF) (Suzuki et al., 2011). mt-tRNALeu and
mt-tRNALys contain 5-taurinomethyl (tm5) and 5-taurinomethyl-
2-thio (tm5s2) modifications, respectively, at U34 (Yasukawa
et al., 2001; Suzuki et al., 2002), and both of these modifications
are critical for decoding their cognate codons (Kirino et al., 2004;
Yasukawa et al., 2001). The absence of these modifications has
been observed in MELAS patients carrying the A3243Gmutation
inmt-tRNALeu and inMERRF patients carrying the A8344Gmuta-
tion in mt-tRNALys (Yasukawa et al., 2001). These results suggest
a critical role for mt-tRNA modifications in the pathogenesis of
human diseases. Nevertheless, knowledge regarding the physio-
logical roles of tRNAmodifications is incomplete, and a complete
investigation of the individual types of mt-tRNA modifications is
required to fully understand the physiological function and mo-
lecular pathology of tRNA modifications in human diseases.
In mammalian mt-tRNAs, 2-methylthio-N6-isopentenyl adeno-
sine (ms2i6A) is a unique modification that is conserved in all
three domains of life (Machnicka et al., 2013). In bacteria, the
ms2 modification of ms2i6A contributes to accurate decoding
by improving tRNA binding to codons (Urbonavicius et al.,
2001; Jenner et al., 2010). However, the physiological impor-
tance of ms2 modifications in mammals is unknown. We have
previously shown that Cdk5rap1 might be responsible for the
ms2 modification of ms2i6A because of its homology to Cdkal1,
which catalyzes ms2t6A modification (Arragain et al., 2010).
Recently, Cdk5rap1 was proposed to catalyze ms2 group inser-
tion in both cytosolic RNAs and mt-tRNAs; however, the exact
substrate tRNA of Cdk5rap1 in mammalian cells remains unclear
(Reiter et al., 2012).
Given the exclusive mitochondrial localization of ms2i6A in
mammals and the implication of this localization in the decoding
process, we hypothesize that Cdk5rap1 might specifically cata-
lyze the ms2 modification of mt-tRNAs and contribute to mito-
chondrial function in vivo. In this study, we validated this hypoth-
esis through a thorough investigation of the physiological
function of the ms2 modification in Cdk5rap1 KO mice. Further-
more, we investigated the pathological implication and the mo-
lecular mechanism of the ms2 modification in MELAS patients.
RESULTS
Cdk5rap1 Catalyzes the Conversion of i6A to ms2i6A in
Mitochondrial tRNAs
Based on the high homology between mammalian Cdk5rap1
and bacterial MiaB, we and another group previously showed
that Cdk5rap1 might be a mammalian methylthiotransferase
that catalyzes the conversion of N6-isopentenyl adenosine
(i6A) to 2-methylthio-N6-isopentenyl adenosine (ms2i6A) (Fig-
ure 1A and see Figure S1A available online; Arragain et al.,
2010; Reiter et al., 2012). To investigate this hypothesis, we
transformed Cdk5rap1 in MiaB-deficient bacteria (DMiaB),
which do not contain ms2 modifications. As expected, the trans-
formation of Cdk5rap1 restored ms2 modifications (Figure 1B).
The conserved cysteine residues in the UPF domain and the
radical SAM domain of MiaB are critical for ms2 modification
through their interaction with two [4Fe-4S] clusters (Forouhar
et al., 2013). Similar to MiaB, the mutation of cysteine residues
in the UFP domain or the radical SAM domain of Cdk5rap1
completely abolished the ms2 modification (Figure 1B).
To prove that Cdk5rap1 is a mitochondrial methylthiotransfer-
ase and to identify its exact substrates, we generated Cdk5rap1
KO mice (Figures S1B–S1D). As expected, the ms2 modification
was completely abolished in KO mice (Figures S1E and S1F).
Cdk5rap1 colocalized with Mitotracker in HeLa cells (Fig-
ure S2A). Cdk5rap1 with a deletion of mitochondrial localization
signal at the N terminus exhibited cytosolic localization but re-
tained its enzyme activity (Figures S2A and S2B). However, no
ms2 modification was detected in Cdk5rap1-deficient mouse
embryonic fibroblast (MEF) cells expressing the cytosolic form
of Cdk5rap1 (Figures S2C and S2D). These results indicate
that Cdk5rap1 localizes on mitochondria and specifically mod-
ifies mt-tRNAs. To identify the exact substrate of Cdk5rap1,
individual mt-tRNA was isolated fromWT and KOmice and sub-
jected to mass spectrometric analysis. The ms2 modificationCewas completely absent at A37 in mt-tRNAPhe, mt-tRNATrp, mt-
tRNATyr, and mt-tRNASer(UCN) isolated from KO mice (Figures
1C–1F). The absence of an ms2 modification did not affect the
nearby tm5 modification at U34 in mt-tRNATrp (Figure S1F).
These results clearly demonstrate that Cdk5rap1 is a two [4Fe-
4S] cluster-containing mitochondrial methylthiotransferase that
specifically converts i6A to ms2i6A at A37 of mt-tRNAPhe, mt-
tRNATrp, mt-tRNATyr, and mt-tRNASer(UCN) in mammalian cells.
The ms2 Modification Controls Codon-Specific
Decoding Fidelity in a Translation Rate-Dependent
Manner
A previous study demonstrated that the ms2 group of 2-methyl-
thio-N6-hydroxyisopentenyl adenosine (ms2io6A) is critical for
the accurate decoding of Tyr and Phe codons (Urbonavicius
et al., 2001). To thoroughly investigate the role of ms2 modifica-
tions of tRNAs during the decoding of their cognate codons, we
utilized a luciferase-based reporter and transformed the plasmid
into aWT strain or the DMiaB strain to detect frameshifting in the
presence or absence of the ms2 modification. The firefly lucif-
erase gene was properly translated only when frameshifting
occurred at the cognate codons read by tRNAPhe, tRNATrp,
tRNATyr, or tRNASer(UCN) (Figure S2E). A deficiency in ms2 modi-
fication induced frameshifting at Phe(TTT) and Tyr(TAT) codons
(Figure 1G). Induction of protein translation by isopropyl-beta-
D-thiogalactopyranoside (IPTG) exaggerated the overall frame-
shifting rate in both the WT and DMiaB strains. In addition
to the Phe(TTT) and Tyr(TAT) codons, there was a significant
increase in ms2-dependent frameshifting at the Tyr(TAC),
Ser(TCT), Ser(TCC), and Ser(TCG) codons, for which frameshift-
ing was not observed without IPTG induction (Figures S1G–S1I).
Importantly, these results show that ms2-dependent frameshift-
ing specifically occurred during the translation of wobble co-
dons, such as Phe(TTT), Tyr(TAT), Ser(TCT), Ser(TCC), and
Ser(TCG), with the exception of the Tyr(TAC) codon, but not
the cognate codons, such as Phe(TTC), Ser(TCA), and Trp(TGG)
(shown in red in Figures S1F–S1I). Furthermore, the ms2-defi-
ciency-evoked frameshifting was fully reversed by transforma-
tion with active Cdk5rap1, but not dominant-negative Cdk5rap1
(Figure 1G). These results demonstrate that ms2 modification is
critical for the accurate decoding of wobble codons correspond-
ing to tRNAPhe, tRNATyr, or tRNASer(UCN) in a translation rate-
dependent manner.
Deficiency of the Mitochondrial ms2 Modification
Attenuates Mitochondrial Translation
To examinemitochondrial protein synthesis, WT or KOMEF cells
were labeled with 35S-methionine for 1 hr and subjected to pulse
chase. The mitochondrial protein synthesis was substantially
decreased in KO MEF cells (Figure 2A). Furthermore, MEF cells
were radioactively labeled and subjected to blue native PAGE
to examine the formation of respiratory complexes. The incorpo-
ration of mitochondrial proteins into complexes I, III, and IV was
substantially decreased in KO MEF, whereas complex V was
unaffected (Figures 2B and 2C). These results suggest that the
deficiency in ms2 modification greatly attenuated mitochondrial
protein synthesis, resulting in impaired complex assembly.
Themaintenance ofmitochondrial OXPHOS subunits is critical
for the electron transport chain, which maintains the restingll Metabolism 21, 428–442, March 3, 2015 ª2015 Elsevier Inc. 429
Figure 1. Cdk5rap1 Is The Mammalian mt-tRNA Methylthiotransferase
(A) Structures of N6-isopentenyladenosine (i6A) and 2-methylthio-N6-isopentenyladenosine (ms2i6A) and the correspondingm/z values are shown. Thems2 group
(S-CH3) is shown in red.
(B) GST-Cdk5rap1 or GST-Cdk5rap1 with Cys-to-Ala mutations (3CA) was transformed into the MiaB-deficient strain (DMiaB). The arrows and arrowhead
indicate the peaks corresponding to i6A and ms2i6A, respectively.
(C–F) Examination of the ms2i6A modification in mt-tRNAPhe (C), mt-tRNATrp (D), mt-tRNATyr (E), and mt-tRNASer(UCN) (F) isolated from WT and KO mice by mass
spectrometry. The mass chromatograms show the peaks corresponding to fragments containing i6A or ms2i6A.
(G) Frameshifting assay. WT and DMiaB bacteria were transformed with Cdk5rap1 or inactive Cdk5rap1 (Cdk5rap1-3CA). The relative ratio of firefly luciferase
activity to renilla luciferase activity (F/R) represents the decoding error. n = 4. Data are mean ± SEM. **p < 0.01, ***p < 0.0001.mitochondrial membrane potential and drives respiration. We
thus investigated the mitochondrial membrane potential in WT
and KO MEF cells. There was a marked increase in cell popula-
tions with very low membrane potential in KO MEF cells (Fig-
ure 2D). Consequently, the oxygen consumption rate in KO cells
was significantly lower than that in WT MEF cells (Figure 2E).
Furthermore, the KO cells quickly lost their mitochondrial mem-
brane potential after treatment with very low doses of rotenone
and FCCP, which had little effect on WT cells (Figures 2F and430 Cell Metabolism 21, 428–442, March 3, 2015 ª2015 Elsevier Inc.2G). These results thus demonstrate that ms2 modifications
of mt-tRNAs are critical for maintaining efficient mitochondrial
translation and respiratory chain.
Deficiency of Mitochondrial ms2 Modification Impairs
OXPHOS in Skeletal Muscle and Heart Tissue without
Affecting Basal Metabolism
To investigate the physiological role of mitochondrial ms2 modi-
fication, we examined the phenotype of KOmice in vivo. Despite
Figure 2. Deficiency in the ms2 Modifications Impaired Mitochondrial Protein Synthesis and Mitochondrial Functions
(A) WT and KOMEF cells were labeled with 35S-Met/Cys and chased for 0 or 24 hr in the presence of emetine for measurement of mitochondrial protein synthesis
(left panels). MEF cells were labeled with 35S-Met/Cys for 1 hr, and total protein synthesis was measured (right panels). CBB staining of gel was used as loading
control.
(B and C) The autoradiogram of blue native PAGE shows a decrease in the incorporation of mitochondrial proteins in complexes I, III, and IV in KO MEF cells (B).
The relative intensity of complex I, III, and IV versus complex V was quantified (C).
(D) The histogram and inserted graph show that KO MEF cells contain a number of mitochondria with low membrane potentials; n = 110 each.
(E) KO cells showed a significant decrease in the oxygen consumption rate (OCR); n = 10 each.
(E–G) Cells were stained with TMRM for measuring membrane potential. The relative membrane potential in the presence of rotenone (F) or FCCP (G) was
analyzed; n = 66 for WT and n = 30 for KO (F); n = 43 for WT and n = 32 for KO (G). Data are mean ± SEM. *p < 0.05.
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Figure 3. The Deficiency in ms2 Modification Impaired Mitochondrial Function In Vivo
(A) Steady-state levels of complex I (CI), complex II (CIII), complex IV (CIV), and complex V (CV) in mitochondria isolated from skeletal muscle and heart tissues
were examined by BN-PAGE.
(B) Steady-state levels of representative proteins of CI-CIV were examined by western blotting. CBB staining was used as loading control.
(C) The activities of CS, CI-CIV in skeletal muscle (left panel), and heart (right panel) of WT and KO mice were examined. n = 4–5.
(D and E) Respiratory couplingwas decreased in Cdk5rap1-deficientmitochondria isolated from skeletal muscle and heart tissuewhen examined using XF24 Flux
Analyzer; n = 4–5.
(F) The steady-state levels of ATP in the skeletal muscle and heart tissue of WT and KO mice were examined; n = 4 each. Data are mean ± SEM. *p < 0.05.themitochondrial dysfunction in KO cells, the Cdk5rap1 KOmice
developed normally without obvious morphological changes in
major tissues (Figures S3A and S3B). The energy expenditure
and glucose metabolism in KOmice were compatible with those
ofWTmice (Figures S3C–S3E). Furthermore, there was no differ-
ence in neurological behaviors between KO and WT mice (Fig-
ures S3F–S3I).
Of all tissues, skeletal muscle and heart tissue are the most
susceptible tissues to mitochondrial dysfunction (DiMauro and
Schon, 2003). We therefore closely examined these two tissues
in KO mice. Substantial decreases in the steady-state levels of
complex I and IV were observed in both skeletal muscle and
heart tissues of KO mice compared with WT mice, with complex
I being markedly affected (Figure 3A). Accordingly, the steady-
state levels of complex I and IV proteins, such as NDUFB8 and432 Cell Metabolism 21, 428–442, March 3, 2015 ª2015 Elsevier Inc.MTCO1, respectively, weremarkedly decreased in skeletal mus-
cle and heart tissues of KO mice compared with WT mice (Fig-
ure 3B). As a result, complex I activity was significantly impaired
in KO mice (58.6% of WT for skeletal muscle and 51.5% of WT
for heart tissue) (Figure 3C). There was a mild but significant
decrease in complex III and complex IV activity in KOmice (mus-
cle: complex III, 88.8% of WT; complex IV, 80.5% of WT; heart:
complex III, 80.7% ofWT, complex IV, 79.8% of WT) (Figure 3C).
The decrease in mitochondrial activity in the skeletal muscle of
KO mice was also confirmed by cytochrome oxidase (COX)
staining (Figure S3J). Accordingly, the oxygen consumption eli-
cited by ADP and FCCP in Cdk5rap1-deficient mitochondria
was significantly lower than that in WT mitochondria, indicating
that electron transport and respiratory coupling were impaired
in the skeletal muscle and heart tissue of KO mice (respiratory
control ratio of the hearts of WT and KO: 4.9 and 3.2, skeletal
muscles of WT and KO: 9.4 and 6.5, respectively; Figures 3D
and 3E). Consequently, the steady-state ATP level in skeletal
muscle and heart tissue of KO mice was lower than that in WT
mice (Figure 3F).
Impairment of mitochondrial function usually exaggerates
mitochondrial remodeling as a compensation mechanism. There
was an increase in the mitochondrial mass in the skeletal muscle
of KOmice as examined by electronmicroscopy andGomori Tri-
chrome staining (Figures 4A, 4B, and S3J). Strikingly, the mito-
chondrial was abnormally enlarged in heart tissue of KO mice
(Figures 4C and 4D). A progressive disruption of cristae was oc-
casionally observed in the mitochondria of the cardiac muscle of
KO mice (arrow in Figure 4C). Furthermore, there was a signifi-
cant increase in citrate synthase activity (Figure 3C) as well as
relative mtDNA content (Figure 4E) in the skeletal muscle of KO
mice.
Reactive oxygen species (ROS) are byproducts of mitochon-
drial electron transport and mainly generated from complexes I
and III (Murphy, 2009). A deficiency of complexes I and III accel-
erates the leakage of ROS from electron transport chain and
contributes to the development of mitochondrial diseases. Given
the marked decrease in complex I protein level in KO mice, we
investigated ROS production in KO mice (Figure 4F). The ROS
level was slightly but significantly higher in KO MEF cells than
that in WT MEF cells. This finding was corroborated by a moder-
ate increase in protein carbonylation (Figure 4G) aswell as oxida-
tive stress-related gene expression in both skeletal muscle and
heart tissues of KO mice (Figure 4H).
To further investigate the impact of deficiency of ms2 modifi-
cation on physiological function, we examined muscular and
cardiac function in vivo. However, the treadmill performance of
KO mice was comparable with that of WT mice (Figure S3K).
The echocardiography examination indicated that no apparent
cardiac defects were present in the KOmice (Figure S3L). Taken
together, these results demonstrate that the deficiency of ms2
modifications in mt-tRNAs impairs mitochondrial protein synthe-
sis, which leads to a reduction of respiratory activity and increase
in ROS in skeletal muscle and heart tissue. However, considering
the overall phenotypes, mice seem to tolerate an up to 50%
reduction of complex I activity due to the loss of ms2 modifica-
tions under sedentary conditions.
Loss ofms2Modifications Accelerates OXPHOSDefects
under Stressed Conditions
The mild phenotype of KO mice prompted us to challenge the
mice with a ketogenic diet (KD; very high fat and ultra-low carbo-
hydrate). Ketone bodies fromKD bypass glycolysis and generate
energy mostly through fatty acid oxidation in mitochondria (Laf-
fel, 1999). Adaptation to this metabolic pressure is accompanied
by mitochondrial rearrangement (Grimsrud et al., 2012). There-
fore, it is conceivable that the accurate regulation of mitochon-
drial protein synthesis by ms2 modification is particularly impor-
tant for mitochondrial remodeling under stressed conditions.
As expected, KD treatment accelerated OXPHOS defects in
the skeletal muscle and heart tissue of KO mice (Figures 4A
and 4B). Complex I activity was significantly impaired in KD-
fed KO mice (48.6% of the KD-fed WT for skeletal muscle and
47.7% of the KD-fed WT for heart tissue) (Figures 5A and 5B).CeIn addition, accelerated decreases in complex III and IV activities
were observed in the KD-fed KO mice (muscle: complex III,
82.9% of the KD-fed WT; complex IV, 62.9% of the KD-fed
WT; heart: complex III, 75% of the KD-fed WT; complex IV,
57.8% of the KD-fed WT).
The OXPHOS defect after KD treatment exaggerated themito-
chondrial remodeling pathway in both WT and KO mice. There
was a 3-fold and 1.5-fold increase in mtDNA content in the
skeletal muscle and heart tissue of both WT and KO mice fed a
KD, respectively (Figure 5C). However, there was no difference
in the mtDNA content in skeletal muscle and heart tissue be-
tween WT and KO mice (Figure 5C). Accordingly, subsequent
electron microscopic examination revealed a marked increase
in mitochondria mass (Figures 5D and 5F). In the skeletal mus-
cles of KO mice fed a KD, mitochondrial proliferation was
observed in both intermyofibrillar and subsarcolemmal mito-
chondria, with the latter drastically increased (Figure 5D). Impor-
tantly, KD-fed KO mice exhibited a considerable population of
mitochondria with disrupted cristae in the skeletal muscle tissue
(arrowheads in Figure 5D). The enlargement of mitochondria and
the disruption of cristae were even more prominent in the heart
tissue of KO mice fed a KD (arrows in Figure 5D). These results
demonstrate that Cdk5rap1-dependent ms2 modification is
crucial for the maintenance of OXPHOS activity and mitochon-
drial morphology under stress.
The acceleration of theOXPHOSdefect in KOmicemaybedue
to the indirect lipotoxicity from the very high-fat diet. However,
the body weight and serum metabolic profiles of KO mice fed a
KD were the same as those of WT mice fed a KD (Figures S4A–
S4C). There was no difference in the locomotor activity or energy
expenditure between theWT and KOmice fed a KD (Figures S4D
and S4E). Interestingly, the glucose level in the KD-fed KO mice
was somewhat lower than that in the KD-fed WT mice (Fig-
ure S4F). Taken together, these results indicate that the progres-
sive OXPHOS defects andmitochondrial degeneration in KD-fed
KO mice directly resulted from a deficiency in Cdk5rap1-depen-
dent ms2 modification during mitochondrial remodeling.
Loss of ms2 Modification Accelerates Muscular and
Cardiac Dysfunction under Stress
The KD-induced OXPHOS defect markedly accelerated the
dysfunction of skeletal muscle and heart tissue in the KO
mice. In a treadmill test, KO mice fed a KD showed a significant
increase in the number of falls and became exhausted as early
as 30 min into the test (Figure 5G). The KO mice also showed
moderate cardiac hypertrophy, as indicated by an increase in
heart volume, heart weight, and left ventricle posterior wall
thickness (Figures S5A–S5C). The percentage of fractional
shortening (FS%) in KO mice fed a KD was significantly lower
than that in WT mice fed a KD (WT, 43% versus KO, 34%; Fig-
ure 5H). In addition to a KD-induced stress model, we utilized a
transverse aortic constriction (TAC) model, which is a standard
model for inducing cardiac dysfunction by pressure overload.
Because the TAC model is also accompanied by global mito-
chondrial remodeling (Dai et al., 2012), we expected that a defi-
ciency in ms2 modification would further accelerate cardiac
dysfunction. Indeed, chronic TAC resulted in a progressive car-
diac hypertrophy, as indicated by an increase in heart weight
and left ventricle posterior wall thickness in KO mice (WT,ll Metabolism 21, 428–442, March 3, 2015 ª2015 Elsevier Inc. 433
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7.5 mg/g body weight; KO, 11.3 mg/g body weight; Figures
S5A and S5D–S5F). In WT mice, the FS% dropped from
51.2% to 34.5% 1 week after TAC but was then maintained un-
til 10 weeks (5 weeks, 32.4; 10 weeks, 31.1; Figure 5I). In
contrast, the FS% in KO mice continuously decreased after
TAC and eventually decreased to as low as 21.7% (Figure 5I).
Further examination in isolated cardiomyocytes revealed that
the cardiac dysfunction observed in the TAC model of KO
mice was associated with a decrease in calcium influx and
contraction rate (Figures 5J and S5G). These results demon-
strate that a deficiency of the ms2 modifications in mt-tRNAs
can cause a catastrophic defect in muscle and heart tissue un-
der stressed conditions.
Deficiencies in ms2 Modification Compromise the
Quality of Mitochondria
Next, we investigated the molecular mechanism underlying the
stress-induced acceleration of OXPHOS defects and cardiomy-
opathy in KO mice. Adaptation to mitochondrial stress requires
coordinated protein synthesis (Dai et al., 2012). Because ms2
modification controls decoding fidelity in a translation-rate-
dependent manner, it is conceivable that a deficiency in ms2
modification under stressed conditions might markedly compro-
misemitochondrial quality aswell as integrity, whichwould result
in severe OXPHOS defects and ultimately lead to myopathy
and cardiac dysfunction. Indeed, a moderate increase in the
complex I level was observed in WT mice treated with KD or
TAC surgery (Figures 6A and 6B). In contrast, the steady-state
levels of complexes I and IV levels were somewhat decreased
in KD-fed and TAC KO mice when compared with NC-fed KO
mice. The mitochondrial stresses increased protein carbonyl-
taion in both WT and KO mice. As a result, the protein carbonyl-
ation level in stressed heart tissues of KO mice was moderately
higher than that in the stressed WT mice (Figure S6A). Impaired
mitochondrial proteostasis exaggerates mitochondrial unfolded
protein response (mt-UPR) (Durieux et al., 2011; Houtkooper
et al., 2013). Accordingly, proteins involved in mtUPR, such
as Yme1l1, Afg3l2, and Lonp1, were upregulated inmitochondria
isolated from the hearts of KO mice treated with KD and
TAC compared with WT mice (Figure 6C). Furthermore, a mar-
ked increase in polyubiquitinated proteins was observed in
mitochondria isolated from the hearts of KO mice under
stressed conditions (Figure 6D). Interestingly, the levels of poly-
ubiquitination were proportional to the levels of cardiac function
(FS%) in stressed KO mice (TAC > KD > NC; Figure 6D; also see
Figures 5H and 5I).
Mitophagy is the hallmark of the existence of compromised
mitochondria. Parkin, an E3 ubiquitin ligase, primes mitophagyFigure 4. Aberrant Mitochondrial Morphology and ROS Metabolism in
(A–D) Mitochondria in skeletal muscle and heart tissue were examined by electro
and increasedmitochondrial mass (B and D). Bars in (A) and the left panels of (C), 1
n = 126; KO, n = 132 in (D).
(E) The relative contents of mtDNA in muscle and heart tissue were examined; n
(F) ROS levels were analyzed by measuring the florescent intensity of CM-H2DCF
n = 3.
(G) Protein carbonylation levels were increased in the mitochondria of skeletal m
(H) Heatmap showing the differentially regulated genes involved in oxidative stres
are mean ± SEM. *p < 0.5, ****p < 0.0001.
Ceby translocation to mitochondria with low membrane potentials
and ubiquitination of mitochondrial proteins (Kubli and Gustafs-
son, 2012). Because cells withms2modification deficiencies had
a low basal mitochondrial membrane potential andwere suscep-
tible to stress-induced depolarization (Figures 2F and 2G), we
hypothesized that mitochondrial stress might exaggerate the
recruitment of Parkin to mitochondria and the acceleration of mi-
tophagy in Cdk5rap1 KO cells. In KO cells treated with FCCP,
most of the Parkin translocated to the mitochondria as soon as
2 hr after treatment, whereas similar translocation was not
observed in WT cells treated with FCCP (Figure 6E; also see
the separated imaged in Figure S6B). A number of large mito-
chondrial aggregates were surrounded by the autophagosomal
membrane protein LC3 in KO cells treated with FCCP, which is
indicative of acceleration of mitophagy (Figure 6F; also see the
separated imaged in Figure S6C). Furthermore, we observed a
number of degenerated mitochondria, with some mitochondria
being degraded in autophagic vacuoles in KD-fed and TAC KO
mice, by electron microscopic examination (Figure 6G). These
results demonstrate that stress-induced mitochondrial remodel-
ing impairedmitochondrial protein synthesis and accelerated the
decomposition of respiratory complexes, which triggered the
mtUPR and mitophagy in KO mice. Thus, the accumulation of
compromised mitochondria ultimately contributes to the devel-
opment of myopathy and cardiac dysfunction.
Association of ms2 Modification with Mitochondrial
Disease
Because the pathological phenotypes of KO mice resembled
those of mitochondrial disease, we speculated that ms2 modifi-
cation might be involved in mitochondrial disease. We investi-
gated the ms2 modification level in peripheral blood cells
collected from MELAS patients who carry the A3243G mutation
(Figure S7A). Because of the limited number of clinical RNA sam-
ples, we adapted the quantitative PCR-based method (Xie et al.,
2013), which was originally developed to examine the ms2 level
of ms2t6A in cytosolic tRNALys(UUU), to sensitively examine the
ms2 modification level of ms2i6A in mt-tRNAs (Figures S7B–
S7E). Strikingly, the heteroplasmy level of mutant mt-DNA was
significantly correlated with the ms2 modification levels of four
mt-tRNAs, but not with the cytosolic tRNALys(UUU) (Figures
7A–7D and S7F). Interestingly, the mutant mtDNA level was not
correlated with the expression level of CDK5RAP1, suggesting
that the decrease in ms2 modifications was not due to a defi-
ciency in CDK5RAP1 (Figures S5D–S5G). Because the A3243G
mutation is located in the mtDNA region corresponding to mt-
tRNALeu(UUR), the decrease in thems2 levels of tRNATrp, tRNAPhe,
tRNATyr, and tRNASer(UCN) was likely not caused by the A3243GKO Mice
n microscopy. KO mice exhibit disrupted mitochondrial morphology (A and C)
0 mm. Bars in the right panels of (C), 0.5 mm.WT, n = 100; KO, n = 112 in (B) and
= 6–9.
DA in WT and MEF cells (left panel). The intensity was quantified (right panel);
uscle and heart tissue in KO mice. NC, negative control.
s response in skeletal muscle and heart tissue of WT and KO mice; n = 4. Data
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mutation but, rather, was due to secondary effects. Cells bearing
A3243Gmutations in mtDNA exhibit a marked reduction of mito-
chondrial protein synthesis and an increase in the oxidative
stress level (Crimi et al., 2005; Ishikawa et al., 2005). Because
Cdk5rap1 contains highly oxidation-sensitive [4Fe-4S] clusters
(Arragain et al., 2010), we speculated that the excess oxidative
stress originated from mutant mitochondria might result in a
collateral inhibition of Cdk5rap1 activity. Indeed, cells treated
with sublethal doses of H2O2 showed a rapid decrease in ms
2
modification, which was completely reversed by adding 10 mM
pyruvate, which serves as an antioxidant (Figures 7E–7G). In
addition, treatment of cells with an NO donor such as SNAP
and NOC18 significantly reduced the ms2 modification level,
which was reversed by the addition of the NO scavenger PTIO
(Figure 7H). Taken together, these results suggest that oxidative
stress-induced decreases in ms2 modifications might compro-
mise the quality of the mitochondria and contribute to the pro-
gression of mitochondrial disease.
DISCUSSION
Regulation of Mitochondrial Protein Synthesis by
Cdk5rap1-Mediated ms2 Modification
In the present study, we revealed the important physiological
functions of ancient mitochondrial ms2 modifications in mice
and human. Using Cdk5rap1 KO mice, we provide direct
evidence that Cdk5rap1 catalyzes the ms2 modifications of
mt-tRNAPhe, mt-tRNATrp, mt-tRNATyr, and mt-tRNASer(UCN) in
mammalian cells. Thems2 group at the A37 of tRNA can directly
participate in crossstrand stackingwith the first nucleotideof the
codon of the mRNA to maintain the reading frame (Jenner et al.,
2010). Indeed, a deficiency in the ms2 modification of ms2i6A
impaired reading frame maintenance in bacteria and caused
defective mitochondrial protein synthesis in Cdk5rap1 KO
mice. Interestingly, nuclear-encoded mitochondrial protein,
such as NDUFB8 in complex I, was also decreased in KO
mice. The indirect decrease of NDUFB8 is most likely due to
the poorly assembled respiratory complexes in KOmice. A pre-
vious study has shown that a deficiency in a single subunit in
complex I could compromise complex formation and cause
the proteolysis of other subunits (Karamanlidis et al., 2013).
Our results thus demonstrate that the ms2 modification of mt-
tRNAs is indispensable for mitochondrial protein synthesis and
the proper assembly of respiratory complexes.Figure 5. Mitochondrial Stresses Accelerated Myopathy and Cardiac D
(A and B)WT and KOmice at 8 weeks oldwere fed for KD for 10weeks. The relative
5–7 each.
(C) The relative mtDNA contents in skeletal muscle and heart tissue of KD-fed WT
mtDNA content in NC-fed WT mice.
(D–F) Electronmicroscopy examination of skeletal muscle and heart tissue show d
mass (E and F) in KD-fed KOmice. Arrowheads and arrows indicate mitochondria
respectively; bars, 10 mm; WT, n = 152; KO, n = 144 in (E) and n = 161; KO, n =
(G) A treadmill test performed at the end of 10 weeks of KD feeding showed tha
compared with the WT mice; n = 5 each.
(H) The fractional shortening (FS) rate in KO mice fed with KD for 10 weeks was
(I) WT and KO mice at 8 weeks old were subject to TAC surgery. The KO mice s
(J) Cardiomyocytes were isolated from WT and KO mice 10 weeks after TAC.
diomyocytes. The inserted graph shows the normalized peak amplitude of calcium
Data are the mean ± SEM. *p < 0.05. **p < 0.01, ***p < 0.001, ****p < 0.0001.
CeWhereas only one transcript of Cdk5rap1 has been found
in mice, multiple splicing variants of human CDK5RAP1 are
listed in the database (Figure S1A). One transcript of human
CDK5RAP1 encodes a short form of CDK5RAP1 without a
mitochondrial localization signal (Q95SZ6-2 in Figure S1A),
which raises the possibility that CDK5RAP1 might regulate
cellular function by modifying cytosol RNAs (Reiter et al.,
2012). However, there was no detectable ms2i6A in total
RNA isolated from KO MEF cells expressing the cytosolic
form of Cdk5rap1 with the enzyme activity preserved. These
results clearly suggest that Cdk5rap1 does not modify nuclear
DNA-derived RNAs in murine cells. Furthermore, the defective
mitochondrial protein synthesis observed in Cdk5rap1 KO
mice may be directly caused by the loss of ms2 modifications
in mt-tRNAs.
Deficiency of ms2 Modification and Its Physiological
Outcome
This study revealed unique phenotypic outcomes of Cdk5rap1
KOmice in response to distinct environmental conditions. Under
sedentary conditions, the skeletal and cardiac functions of the
Cdk5rap1 KO mice were compatible with those of the WT
mice, despite the marked decrease in respiratory activities and
regardless of the increase of oxidative stress. The mitochondrial
dysfunction in KO mice might be compensated by the remodel-
ing of mitonuclear protein balance, which serves as a protective
mechanism by inducing mtUPR (Houtkooper et al., 2013).
Indeed, in contrast to the decrease of mitochondrial protein syn-
thesis, several cytosolic proteins appear to be upregulated in KO
cells (right panels in Figure 2A). This mitonuclear protein imbal-
ance might contribute to the upregulation of basal mtUPR in
muscle and heart tissues of KO mice (Figure 6C). Furthermore,
a collective increase of ROS metabolism genes, including ROS
scavenger genes such as ApoE, DHCR24, and SRXN1, might
ameliorate oxidative stress and protect themuscular and cardiac
functions in KO mice. Similar to our results, previous studies
have found no adverse phenotypes under basal conditions in
transgenic mice with respiratory defects (Karamanlidis et al.,
2013; Wenz et al., 2009). Our results thus support the current
perspective thatmitochondrial dysfunction, depending on its de-
gree, may not immediately produce a pathological phenotype
under sedentary conditions.
In contrast, under stressed conditions, Cdkrap1 KO mice ex-
hibited apparent skeletal muscle and heart dysfunctions. Theysfunction in ms2-Deficient Mice
activities of CS, CI-CIV in skeletal muscle (A), and heart (B) were examined; n =
and KO mice were examined; n = 6–7. The dashed lines represent the relative
isrupted mitochondrial architecture (D) and amarked increase in mitochondrial
with abnormal cristae in skeletal muscle and heart tissues of KD-fed KOmice,
130 in (F).
t the KD induced a higher number of falls in the KO mice during acute excise
significantly lower than that in KO-fed WT mice; n = 10–11.
howed a significant decrease in FS after TAC surgery.
Calcium imaging revealed a decrease in the peak calcium influx in KO car-
influx in cardiomyocytes fromWT and KOmice; n = 13 forWT and n = 6 for KO.
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defective mitochondrial protein synthesis caused a marked
decrease in protein levels and activities of complexes I and IV
in KO mice under stressed conditions. The progressive disrup-
tion of respiratory complexes, which exaggerates mtUPR and
mitophagy, thus largely compromised mitochondria quality and
led to myopathy in KO mice. Recent studies have shown that
Parkin-mediated mitophagy is critical for the removal of
damagedmitochondria and thus protects cardiac function under
stressed conditions (Hoshino et al., 2013; Chen and Dorn, 2013).
However, given the observation of a number of degenerated
mitochondria in KOmice (Figures 4D and 5G), the extent of mito-
chondria damage in KOmice was likely beyond themaintenance
capacity of mitophagy, which ultimately led to catastrophic mito-
chondrial dysfunction and myopathy. In addition, the accelera-
tion of complex I defect was associated with a modest increase
of oxidative stress, which could trigger mtUPR and cause cyto-
toxicity in stressed KO mice (Runkel et al., 2013). However,
compared with the progressive impairment of mitochondria
quality, the degree of increase of ROS after mitochondrial stress
was rather small in stressed KO mice. Our results thus suggest
that ROS might also contribute to the pathogenesis, but to a
limited extent. The accumulation of malfunctioning mitochondria
is likely the primary cause of the progression of myopathy in KO
mice.
Regulation of ms2 Modification by Oxidative Stress and
Its Association with Human Disease
An important finding of this study is that the ms2 modification
levels were reduced in MELAS patients carrying the A3243G
mutation in mt-tRNALeu. This result is surprising because mt-
tRNALeu does not contain an ms2 modification. Previous
studies have shown that the deficiency of taurine modification
in mt-tRNALeu carrying the A3243G mutation is the primary
cause of MELAS (Kirino et al., 2005; Yasukawa et al., 2001).
Given the significant association of the heteroplasmy level
with the ms2 modification level in MEALS patients, our results
suggest that the myopathy in MELAS is caused not only by a
decoding error at the Leu codon but also by decoding errors
occurring at multiple codons, including Leu, Phe, Tyr, Trp,
and Ser codons.
The reason A3243G in mt-tRNALeu is associated with
decreased modifications in other mt-tRNAs remains unclear.
Although further studies are required to reveal the molecular
mechanism, our results suggest that oxidative stress may be
one of the reasons for this finding. Cdk5rap1 requires two
[4Fe-4S] clusters for ms2 group insertion (Forouhar et al.,
2013); therefore, it is conceivable that ROS, such as H2O2 orFigure 6. The Deficiency in ms2 Modification Compromises Mitochond
(A) Steady-state levels of CI, CIII, CIV, and CV in heart tissue in WT and KO mice
(B) The steady-state levels of CI protein NDUFB8, CIV protein MTCOI, and CIII pro
surgery were examined by BN-PAGE followed by western blotting. UQCRC2 wa
(C) The protein levels of Yme1l1, Afg 3l2, and Lonp1 were examined in heart tissu
stained with CBB were used as a loading control.
(D) Enhanced polyubiquitination was observed in the mitochondria in the hearts
(E) WT and KO cells transfected with Parkin-YFP were treated with 10 mM FCCP
(F) WT and KO cells were treated with 10 mMFCCP for 2 and 4 hr. The cells were th
mitochondria surrounded by the LC3 protein and is magnified in the bottom pan
(G) Electron microscopy of mitochondria in heart tissue from WT and KO mice tr
10 mm.
CeONOO, may oxidize these [4Fe-4S] clusters and inactivate
Cdk5rap1. In support of our hypothesis, ROS-treated cells ex-
hibited a rapid decrease in ms2 modification that was effectively
reversed by antioxidants. Thus, ROS generated by the mutation
in mt-tRNALeu might impair Cdk5RAP1-mediated ms2 modifica-
tion, which might further amplify mitochondrial dysfunction and
ultimately accelerate myopathy in MELAS patients. In addition
to mitochondrial disease, ms2 modifications might be involved
in awide variety of human diseases in which ROS have been pre-
viously implicated, such as cardiac dysfunction and cancer
(Schieber and Chandel, 2014).
In conclusion, this study reveals a unique quality control
system in mitochondria by which the ms2 modification of mt-
tRNAs dynamically regulates mitochondrial protein synthesis
and contributes to the development of myopathy in vivo. Our
findings have important physiological implications for the
basic mechanism of mitochondrial protein synthesis and pro-
vide insights into the pathological mechanism of mitochondrial
disease.
EXPERIMENTAL PROCEDURES
Please see the Supplemental Experimental Procedures for additional details.
Animals
Cdk5rap1 KO mice were generated by crossing transgenic mice with exon 5
and 6 of Cdk5rap1 floxed with LoxP sequence, with transgenic mice express-
ing Cre recombinase under the control of the CAG promoter. Mice were back-
crossed to C57BL6/J mice for at least seven generations to eliminate Cre
transgene and control genetic background. Littermates of WT and KO mice
(8–12 weeks old) were used for experiments unless otherwise specified. Ani-
mals were housed at 25Cwith 12 hr light and 12 hr dark cycles. A KDwas pur-
chased from Research Diets (D12369B). All animal procedures were approved
by the Animal Ethics Committee of Kumamoto University (Approval ID, C25-
163). Detailed information on genotyping can be found in the Supplemental
Experimental Procedures.
Luciferase Assay
E. coli colonies were transformed with plasmids encoding dual luciferase
for detecting decoding error, GST-Cdk5rap1, or dominant-negative GST-
Cdk5rap1. Colonies were cultured at 37C, and isopropyl b-D-1-thiogalacto-
pyranoside (IPTG) was added to the cultures at a final concentration of
1 mM. After 1 hr of incubation, the cultures were harvested for the luciferase
assay using the Dual-Luciferase Reporter Assay System (Promega). Detailed
procedures for detecting decoding error can be found in the Supplemental
Experimental Procedures.
Cell Culture and Transfection
Mammalian cells were grown in DMEMhigh-glucosemedium (GIBCO) supple-
mented with 10% fetal bovine serum (FBS, HyClone) at 37C and 5% CO2.rial Protein Quality under Stressed Conditions
treated with NC, KD, and TAC surgery were examined by BN-PAGE.
tein UQCRC2 in heart tissue in WT and KOmice treated with NC, KD, and TAC
s used as a loading control.
es from WT and KO mice treated with NC, KD, and TAC surgery. Membranes
of KO mice under each stress.
for 2 and 4 hr; bar, 10 mm.
en stained with an anti-LC3 antibody andMitotracker. The inserted box shows
els; bar, 10 mm.
eated with KD or TAC surgery. Arrows indicate the autophagic vacuoles; bar,
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Figure 7. Association of ms2 Modifications
with MELAS
(A–D) Negative correlation of the ms2 modifica-
tion level of mt-tRNATrp (A), mt-tRNAPhe (B), mt-
tRNASer(UCN) (C), or mt-tRNATyr (D) with the heter-
oplasmy level in MELAS patients; n = 18 each.
(E) Treatment with H2O2 reduced the level of ms
2
modification of mt-tRNAs in HeLa cells. Cells were
treated with 10 mMor 50 mMH2O2 for 24 hr, and the
ms2 modification levels were examined by qPCR;
n = 4 each.
(F) Time-dependent decreases in ms2 modification
after H2O2 treatment in HeLa cells. Cells were
treated with 50 mM H2O2 for 6, 12, and 24 hr; n = 4
each.
(G) HeLa cells were treated with 50 mM H2O2 for
24 hr in the presence or absence of 10 mM pyru-
vate. The decrease in the ms2 modification level
was prevented by pyruvate; n = 4 each.
(H) HeLa cells were treated with NO donors,
100 mM SNAP or 100 mM NOC18 for 24 hr in the
presence or absence of PTIO. The ms2 modifica-
tion level of mt-tRNATrp was examined by qPCR;
n = 4 each. Data are the mean ± SEM. *p < 0.05.
**p < 0.01, ****p < 0.0001.Transfection of the plasmid DNA was performed with Lipofectamine 2000
(Invitrogen).
Oxygen Consumption
The oxygen consumption rate in MEF cells and intact mitochondria was
measured using an XF24 Analyzer (Seahorse Bioscience). The oxygen con-
sumption rate was normalized to the total protein concentration for measure-
ment in cells. Detailed procedures for the respiratory assay can be found in the
Supplemental Experimental Procedures.
Gene Expression Assay
RNA was extracted from tissues using Trizol (Invitrogen) following the manu-
facturer’s instructions. Quantitative PCR (qPCR) was performed using SYBR
Premix Ex Taq (TAKARA). For examination of the expression levels of oxidative
response genes, the results were normalized to the geometricmean ofmultiple
reference genes (Hprt1, RPL13A, B2M, GAPDH, ACT). Then, a Z-transforma-
tion was applied to the results to calculate the Z score and construct a heat-440 Cell Metabolism 21, 428–442, March 3, 2015 ª2015 Elsevier Inc.map (Cheadle et al., 2003). The sequences of
primers used can be found in the Supplemental
Experimental Procedures.
Analysis of tRNA Modification
Total RNAswere isolated frombacteria and tissues
using Trizol reagent (Invitrogen). RNA was di-
gested with Nuclease P1 (Sigma) and subjected
to mass spectrometry (Agilent 6460). For detecting
tRNAmodification using the qPCR-basedmethod,
we adapted a protocol described previously (Xie
et al., 2013). Detailed procedures for the mass
spectrometry and qPCR method can be found in
the Supplemental Experimental Procedures. To
measure the tRNAmodification level in blood sam-
ples, blood samples were collected from MELAS
patients using standard procedures approved by
Kurume University (IRB#9715).
ATP Measurement
Small pieces of skeletal muscle and heart tissue
were immediately dissected after sacrificing miceand snap frozen in liquid nitrogen until measurement. ATPwasmeasured using
the ATP Bioluminescence Assay Kit following the manufacturer’s protocol
(TA100, WAKO). The luminescence was measured using a Centro XS3
LB960 (Berthold) and normalized to total protein concentration.
Cardiac Function Examination
Echocardiographs were examined in M-mode while the mice were under
anesthesia using the Vevo2100 system (Fujifilm VisualSonics, Inc.) according
to the manufacturer’s instructions.
Statistical Analysis
Statistical analyses were performed using Prism 6 Software (GraphPad Soft-
ware). An unpaired Student t test was used to test the differences between
two groups. Analysis of variance (one-way ANOVA or two-way ANOVA) was
used to test the difference among multiple groups followed by a post hoc ex-
amination of the p value between two groups. A two-tailed p value of 0.05 was
considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article at http://dx.doi.org/10.
1016/j.cmet.2015.01.019.
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